Sequencing your Whole Genome for Exome price

Now you can sequence your whole genome for exome price!

Whole genome sequencing (WGS) is a technology which has revolutionized the field of genetics, allowing researchers and clinicians to study the entire DNA sequence of an organism. With the advent of next generation sequencing technologies, the cost if whole genome sequencing has decreased significantly in recent years.

The price of whole genome sequencing varies depending on several factors such as the sequencing patform used, the amount of coverage required, and the complexity of the sample. The most commonly used NGS platforms for WGS is Illumina, and the price of whole genome sequencing has decreased rapidly, from $1 million per genome in 2007 to $1,000 genome in 2015 and it’s expected to drop to $200 for this year.

Why whole genome sequencing?

Whole genome sequencing is the most comprehensive genetic testing that covers the entire human genome. An exome is the part of the genome that codes for proteins, and it represents about 1-2% of the total genome. Until now, exome sequencing has been known as the most affordable NGS testing method because it is less expensive than WGS and could detect a relatively large number of diseases compared to its’ coverage of coding regions.

However, the ‘non-coding’ parts of DNA also help to regulate DNA transcription as well. So it’s not surprise that sequencing the entire genome can provide a wealth of information. For a variety of reasons, the price of whole genome sequencing has been falling recently and catching up with the price of exomes, which have traditionally seemed cheaper. It means that the falling price of WGS is making it more accessible to people who want to obtain comprehensive genetic information.

Feel free to contact us!

3billion is committed to providing our customers with the most reasonable price for genetic testing to end the rare disease diagnostic odyssey for more patients. If have any questions or need help, please feel free to contact us at the bottom of the support page and we’ll get back you as soon as possible.

Cases diagnosed with 3B-GENOME

In the following articles you can see some cases diagnosed with 3B-GENOME, 3billion’s WGS based testing service.

• Myotonic dystrophy 1 / DMPK repeat expansion
• Autosomal recessive Deafness 22 / OTOA Inversion
• Type I Neurofibromatosis / NF1 intron case

Meet 3billion at the ACMG 2023 Annual Meeting

At the ACMG 2023 meeting, 3billion will promote it’s whole genome sequencing (WGS) based testing service 3B-GENOME and the underlying technology. Unlike conventional panel testing and whole exome sequencing, whole genome sequencing can analyse different types of mutations present throughout the genome, making it more accurate diagnostic method.

At the event, three research posters will showcase 3billion’s technology and clinical cases, which have been proven through participation in various national research projects.

3billion is looking forward to meeting with a wide range of healthcare professionals and researchers at the ACMG 2023 annual conference.

Stop by booth #523 and meet the 3billion team!